Cel Sci Corporation (CVM)

[jamesnhansen]

To Be or Not to Be. The injection?

lightrock, I wrestled the “118 issue” to the mat two weeks ago. Two solid days reading the Edgar filings.

The answer was not in the Ks or Qs—it was deep in the PIPEs. CVM disclosed there three times by my count that regarding [img][/img]the 118 “all or some might not be assessable.” I did not find any reference to the 118 “returning.” So I emailed Gavin, and he wrote “that issue was settled.”

It kind of reminded of the Adams Family scene where a friend of Gomez said, “You’re such a lady killer!” And responded, “Acquitted!”

As best I call tell, the main reason that InVentif was canned was because the were not enrolling the trial fast enough. It’s NOT because they selected inappropriate enrollees. (Please korreckt me, anyone.) The CRO was involved in a takeover. So, I don’t think that any data was missed from this group or that there is any deviation from the tenor of the later enrollees. Rather we should view this subset as hostages in a legal war. They were never mistreated or mishandled or roll miss-selected.

The above is a segway to another issue: last week when Jaye Thompson announced that she was taking a full time position at (stock-not-named-so-bot-doesn’t-cancel-me, so-look-it-up-yourself), that stock doubled on high volume. She’s a biostatistics jockey and leading their P3 design. She’s a $multi-million cred asset. She also formerly worked at InVentif. Was she there during the unpleasantness period? During the lawsuit? In 2013-14? Anyone know?

“Inquiring minds need to know.” The Inquirer.

Cheers from Oregon,

Jim